Literature DB >> 8157038

Plasma levels of piperacillin and vancomycin used as prophylaxis in liver transplant patients.

M Dupon1, G Janvier, G Vinçon, S Winnock, F Demotes-Mainard, O Capeyron, J Saric.   

Abstract

The pharmacokinetics of piperacillin and vancomycin used intravenously as antibioprophylaxis were measured in the plasma and bile during orthotopic liver transplantation. Piperacillin (4 g and then 2 g every 4 h) and vancomycin (1 g and then 0.5 g every 6 h) were infused in 10 patients. During vascular clamping without venovenous bypass, clearance of both antibiotics decreased in relation to renal insufficiency. During the surgical procedure, volume of distribution of both drugs increased because of fluid redistribution. The peaks of piperacillin after first, second and third administrations were respectively 314, 265 and 210 mg.l-1, while trough levels were 46.5, 55.2 and 54.5 mg.l-1. The peaks of vancomycin were 54.4, 49.6 and 40.9 mg.l-1, while first and second trough levels were 9.5 and 12 mg.l-1. These plasma concentrations were quite similar to levels reported in healthy subjects despite large blood loss and fluid replacement. However, piperacillin trough concentrations (< 64 mg/l) were too low in relation to its concentration-dependent antibacterial activity and vancomycin peak concentrations (> or = 40 mg/l) were slightly too high in relation to its toxicity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8157038     DOI: 10.1007/bf00315309

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  26 in total

1.  The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection.

Authors:  D C Classen; R S Evans; S L Pestotnik; S D Horn; R L Menlove; J P Burke
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

2.  Micro-method for the determination of piperacillin in plasma by high-performance liquid chromatography.

Authors:  V Gautier; F Demotes-Mainard; M Foureau; G Vinçon
Journal:  J Pharm Biomed Anal       Date:  1991       Impact factor: 3.935

3.  Pharmacokinetics of mezlocillin in patients with hepatobiliary dysfunction.

Authors:  B R Meyers; E S Srulevitch; H S Sacks; S Z Hirschman; T M Worner; G P Wormser; J Jacobson
Journal:  J Antimicrob Chemother       Date:  1986-12       Impact factor: 5.790

4.  Biliary pharmacokinetic profile of piperacillin: experimental data and evaluation in man.

Authors:  J M Brogard; F Jehl; J F Blickle; M Dorner; J P Arnaud; H Monteil
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1990-11

5.  Antibiotics in biliary disease: the relative importance of antibiotic concentrations in the bile and serum.

Authors:  M R Keighley; R B Drysdale; A H Quoraishi; D W Burdon; J Alexander-Willians
Journal:  Gut       Date:  1976-07       Impact factor: 23.059

Review 6.  The acylampicillins: mezlocillin, piperacillin, and azlocillin.

Authors:  G L Drusano; S C Schimpff; W L Hewitt
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

7.  Infections after liver transplantation. An analysis of 101 consecutive cases.

Authors:  S Kusne; J S Dummer; N Singh; S Iwatsuki; L Makowka; C Esquivel; A G Tzakis; T E Starzl; M Ho
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889

8.  Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics.

Authors:  B R Meyers; S Z Hirschman; L Strougo; E Srulevitch
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

9.  Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis.

Authors:  J A Giron; B R Meyers; S Z Hirschman; E Srulevitch
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

10.  Biliary concentrations of piperacillin in patients undergoing cholecystectomy.

Authors:  J A Giron; B R Meyers; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.